These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26781)

  • 21. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
    Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
    Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
    Barbelivien A; Nyman L; Haapalinna A; Sirviö J
    Pharmacol Toxicol; 2001 Jun; 88(6):304-12. PubMed ID: 11453370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of subchronic administration of psychoactive substances on the circadian rhythm of urinary corticosterone excretion in rats.
    Häusler A; Hauser K; Meeker JB
    Psychoneuroendocrinology; 1985; 10(4):421-9. PubMed ID: 3878973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Down-regulation of [3H]5-hydroxytryptamine binding sites in chick embryo brain by monoamine oxidase inhibitors or fenfluramine and potentiation by d,l-5-hydroxytryptophan.
    Soblosky JS; DuMontier G; Jeng I
    J Neurochem; 1985 Dec; 45(6):1923-31. PubMed ID: 3932597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of brain monoamines in the fatal hyperthermia induced by pethidine or imipramine in rabbits pretreated with a monoamine oxidase inhibitor.
    Gong SN; Rogers KJ
    Br J Pharmacol; 1973 May; 48(1):12-8. PubMed ID: 4269286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Influence of substances that change the serotonin level of the brain on the analgesic effect of promedol in rats].
    Murakhina LK
    Farmakol Toksikol; 1976; 39(1):31-5. PubMed ID: 1082823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antihypertensive effects of fluoxetine and L-5-hydroxytryptophan in rats.
    Fuller RW; Holland DR; Yen TT; Bemis KG; Stamm NB
    Life Sci; 1979 Oct; 25(14):1237-42. PubMed ID: 316092
    [No Abstract]   [Full Text] [Related]  

  • 28. Interaction of selective inhibitors of monoamine oxidase with pethidine in rabbits.
    Jounela AJ; Mattila MJ; Knoll J
    Biochem Pharmacol; 1977 Apr; 26(8):806-8. PubMed ID: 856214
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison of the inhibitory effects of propargylamine and pargyline on brain and liver monoamine oxidase activity.
    Abeles RH; Tashjian AH
    Biochem Pharmacol; 1975 Jan; 24(2):307-8. PubMed ID: 1111545
    [No Abstract]   [Full Text] [Related]  

  • 30. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The sensitivity of hippocampal pyramidal neurons to serotonin in vitro: effect of prolonged treatment with clorgyline or clomipramine.
    Olpe HR; Schellenberg A; Jones RS
    J Neural Transm; 1984; 60(3-4):265-71. PubMed ID: 6527140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yohimbine: behavioral and biochemical effects in mice.
    Sanghvi I; Gershon S
    Arch Int Pharmacodyn Ther; 1974 Jul; 210(1):108-20. PubMed ID: 4280277
    [No Abstract]   [Full Text] [Related]  

  • 33. The MAO-B inhibitor deprenyl, but not the MAO-A inhibitor clorgyline, potentiates the neurotoxicity of p-chloroamphetamine.
    Benmansour S; Brunswick DJ
    Brain Res; 1994 Jul; 650(2):305-12. PubMed ID: 7953696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of brain monoamines in the fatal hyperthermia induced by pethidine or imipramine in rabbits pretreated with pargyline.
    Gong SN; Rogers KJ
    Br J Pharmacol; 1971 Aug; 42(4):646P. PubMed ID: 4256025
    [No Abstract]   [Full Text] [Related]  

  • 35. Modification by monoamine oxidase inhibitors of the analgesic, hypothermic and toxic actions of morphine and pethidine in mice.
    Botting R; Bower S; Eason CT; Hutson PH; Wells L
    J Pharm Pharmacol; 1978 Jan; 30(1):36-40. PubMed ID: 22722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-stimulation responses are altered following long-term but not short-term treatment with clorgyline.
    Aulakh CS; Cohen RM; Pradhan SN; Murphy DL
    Brain Res; 1983 Jul; 270(2):383-6. PubMed ID: 6883106
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of chronic cord transection on the effects of 5-hydroxytryptophan, l-tryptophan and pargyline on spinal neuronal activity.
    Shibuya T; Anderson EG
    J Pharmacol Exp Ther; 1968 Nov; 164(1):185-90. PubMed ID: 5303400
    [No Abstract]   [Full Text] [Related]  

  • 38. Evidence that the accumulation of 5-hydroxytryptamine in the liver but not in the brain may cause the hypoglycaemia induced by 5-hydroxytryptophan.
    Endo Y
    Br J Pharmacol; 1985 Jul; 85(3):591-8. PubMed ID: 3875380
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of clomipramine and clorgyline on the sensitivity of cortical neurons to serotonin: effect of chronic treatment.
    Olpe HR
    Eur J Pharmacol; 1981 Jan; 69(3):375-7. PubMed ID: 7215435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute inhibition of monoamine oxidase and ischemic preconditioning in isolated rat hearts: interference with postischemic functional recovery but no effect on infarct size reduction.
    Dănilă MD; Privistirescu AI; Mirica SN; Sturza A; Ordodi V; Noveanu L; Duicu OM; Muntean DM
    Can J Physiol Pharmacol; 2015 Sep; 93(9):819-25. PubMed ID: 26322912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.